Structures by: Bylikin S.
Total: 4
(S)-(1-(methylsulfonyl)pyrrolidin-2-yl)(2,2,6,6-tetramethyl-1,4,2,6-oxazadisilinan-4-yl)methanone
C12H26N2O4SSi2
RSC Adv. (2016)
a=7.436(4)Å b=9.474(6)Å c=14.125(9)Å
α=90° β=104.082(9)° γ=90°
N-methyl-N-(2-oxo-2-(2,2,6,6-tetramethyl-1,4,2,6-oxazadisilinan-4-yl)ethyl)methanesulfonamide
C10H24N2O4SSi2
RSC Adv. (2016)
a=15.1089(9)Å b=6.6275(4)Å c=16.4442(10)Å
α=90° β=98.7620(10)° γ=90°
(S)-(1-(methylsulfonyl)pyrrolidin-2-yl)(2,2,6,6-tetramethyl-1,4,2,6-oxazadisilinan-4-yl)methanone
C12H26N2O4SSi2
RSC Adv. (2016)
a=9.6000(5)Å b=14.2422(7)Å c=27.0844(14)Å
α=90° β=90° γ=90°
(S)-N,N-bis((fluorodimethylsilyl)methyl)-1-(methylsulfonyl)pyrrolidine-2-carboxamide
C12H26F2N2O3SSi2
RSC Adv. (2016)
a=13.0441(9)Å b=15.9282(11)Å c=18.2980(13)Å
α=90° β=90° γ=90°